[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100466476":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":37,"centralContacts":42,"locations":48,"responsibleParty":65,"collaborators":11,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":11,"eligibilityCriteria":73,"healthyVolunteers":70,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":11,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":11,"overallStatus":50,"whyStopped":11,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"2mA transcranial direct current stimulation","EXPERIMENTAL",null,[13],"Device: 2 mA transcranial direct current stimulation (tDCS)",{"label":15,"type":10,"description":11,"interventionNames":16},"1mA transcranial direct current stimulation",[17],"Device: 1 mA transcranial direct current stimulation (tDCS)",{"label":19,"type":20,"description":11,"interventionNames":21},"Sham transcranial direct current stimulation","SHAM_COMPARATOR",[22],"Device: Sham transcranial direct current stimulation (tDCS)",[24,29,33],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"DEVICE","2 mA transcranial direct current stimulation (tDCS)","tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 2mA condition, the investigators will assist the administration of a 2mA current stimulation from the device.",[9],{"type":25,"name":30,"description":31,"armGroupLabels":32,"otherNames":11},"1 mA transcranial direct current stimulation (tDCS)","tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the 1mA condition, the investigators will assist the administration of a 1mA current stimulation from the device.",[15],{"type":25,"name":34,"description":35,"armGroupLabels":36,"otherNames":11},"Sham transcranial direct current stimulation (tDCS)","tDCS is a non-invasive neuromodulatory technique that has previously demonstrated the ability to transiently modulate cognitive domains in both healthy and psychiatric populations. In the sham condition, the investigators will assist the administration of a sham stimulation from the device.",[19],[38],{"name":39,"affiliation":40,"role":41},"Joan Camprodon, MD, PHD, MPH","MGB: Division of Neuropsychiatry and Neuromodulation","PRINCIPAL_INVESTIGATOR",[43],{"name":44,"role":45,"phone":46,"phoneExt":11,"email":47},"DNN Inbox","CONTACT","6177265348","mghdnn@mgh.harvard.edu",[49],{"facility":5,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"RECRUITING","Charlestown","Massachusetts","02129","United States","US",{"type":57,"coordinates":58},"Point",[59,60],-71.062,42.37787,{"lat":60,"lon":59},[63],{"name":44,"role":45,"phone":64,"phoneExt":11,"email":47},"6177268780",{"type":41,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Joan A Camprodon, MD MPH PhD","Division Chief - Neuropsychiatry & Neuromodulation","100466476","home-based-transcranial-direct-current-stimulation-tdcs-for-treatment-of-attention-deficithyperactivity-disorder-adhd-100466476",false,"NCT05354232","Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit\u002FHyperactivity Disorder (ADHD)","Inclusion Criteria:\n\n1. Male and female outpatients 18-65 years of age\n2. A diagnosis of ADD\u002FADHD or meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.\n\nExclusion Criteria:\n\n1. Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, VP shunt, pacemakers, pregnancy.\n2. Active substance dependence (except for tobacco).\n3. Pregnant or nursing females.\n4. Inability to participate in testing procedures.\n5. Premorbid neurological conditions (including neurovascular and neurodegenerative diseases such as traumatic brain injury, stroke, Parkinson's, AD and other dementias) and severe psychiatric disorders (bipolar disorder, schizophrenia).","ALL","18 Years","65 Years",{"count":78,"type":79},60,"ESTIMATED","INTERVENTIONAL",[82],"NA","The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.",[85,86],"Attention Deficit Disorder","Attention Deficit Disorder With Hyperactivity","2025-12-05",{"date":89,"type":90},"2025-12-12","ACTUAL",{"date":92,"type":90},"2022-07-01",{"date":94,"type":79},"2026-05",{"name":5,"class":6},1]